First Time Loading...

Innovent Biologics Inc
HKEX:1801

Watchlist Manager
Innovent Biologics Inc Logo
Innovent Biologics Inc
HKEX:1801
Watchlist
Price: 40.15 HKD 0.25%
Updated: May 21, 2024

Innovent Biologics Inc
Interest Income Expense

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Innovent Biologics Inc
Interest Income Expense Peer Comparison

Comparables:
6160
603392
S
002252
300122
300896

Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors

Company Interest Income Expense CAGR 3Y CAGR 5Y CAGR 10Y
Innovent Biologics Inc
HKEX:1801
Interest Income Expense
¥445.8m
CAGR 3-Years
N/A
CAGR 5-Years
84%
CAGR 10-Years
N/A
Beigene Ltd
HKEX:6160
Interest Income Expense
-¥59.3m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Interest Income Expense
¥217.7m
CAGR 3-Years
N/A
CAGR 5-Years
134%
CAGR 10-Years
N/A
S
Shanghai RAAS Blood Products Co Ltd
SZSE:002252
Interest Income Expense
¥25.8m
CAGR 3-Years
-66%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Interest Income Expense
-¥33.6m
CAGR 3-Years
38%
CAGR 5-Years
-3%
CAGR 10-Years
N/A
Imeik Technology Development Co Ltd
SZSE:300896
Interest Income Expense
¥100.8m
CAGR 3-Years
126%
CAGR 5-Years
96%
CAGR 10-Years
N/A

See Also

What is Innovent Biologics Inc's Interest Income Expense?
Interest Income Expense
445.8m CNY

Based on the financial report for Dec 31, 2023, Innovent Biologics Inc's Interest Income Expense amounts to 445.8m CNY.

What is Innovent Biologics Inc's Interest Income Expense growth rate?
Interest Income Expense CAGR 5Y
84%

Over the last year, the Interest Income Expense growth was -47%.